Menu

“Father of Modern Hematology” Dies

Australian researcher Donald Metcalf, whose discoveries transformed cancer treatment, has passed away at age 85.

Dec 17, 2014
Molly Sharlach

WEHIDonald Metcalf, whose studies of blood cell formation led to improved outcomes for cancer patients, died this week (December 15) at the age of 85. He was diagnosed with metastatic pancreatic cancer in August.

Metcalf earned a medical degree at the University of Sydney in 1953, and spent 60 years as an investigator at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, where he characterized colony stimulating factors (CSFs), which regulate the production of white blood cells. His work on CSFs led to the widespread clinical use of these growth factors to restore immune function in cancer patients undergoing chemotherapy. 

“CSFs are now standard treatment and every year the number of people alive because of Don’s work grows,” wrote WEHI Director Douglas Hilton in a tribute to Metcalf. “There can be no greater legacy for a medical researcher.”

“When he was diagnosed with cancer in August . . . the two things he wanted to do was spend as much time as possible with his wife, Jo, and his daughters, but also to continue to do his research,” Hilton told the Australia’s ABC. “His solution was to have his microscope, which was his valued possession at work, shipped home and it sat on his dining room table . . . he’d be able to sneak in some experiments in the afternoon and then spend the time with his wife, so really that kept going until about a month ago.”

Metcalf’s research has also impacted the fields of blood stem cell transplantation and rheumatoid arthritis treatment. He received several awards during his career, including the Albert Lasker Clinical Medical Research Award in 1993.

He is survived by his wife, four daughters, and six grandchildren.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!